Ocuphire Pharma Inc OCUP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 02/03/23 EST
3.50UNCH (UNCH)
Volume
68,872
52 week range
1.78 - 4.43
Loading...
  • Open3.48
  • Day High3.60
  • Day Low3.41
  • Prev Close3.50
  • 52 Week High4.43
  • 52 Week High Date03/25/22
  • 52 Week Low1.78
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap72.825M
  • Shares Out20.81M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-0.85

KEY STATS

  • Open3.48
  • Day High3.60
  • Day Low3.41
  • Prev Close3.50
  • 52 Week High4.43
  • 52 Week High Date03/25/22
  • 52 Week Low1.78
  • 52 Week Low Date06/16/22
  • Market Cap72.825M
  • Shares Out20.81M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-0.85

RATIOS/PROFITABILITY

  • EPS (TTM)-1.18
  • P/E (TTM)-2.98
  • Fwd P/E (NTM)6.51
  • EBITDA (TTM)-22.13M
  • ROE (TTM)-137.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,512.27%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/10/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocuphire Pharma Inc

 

Profile

MORE
Ocuphire Pharma, Inc. is an ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its products include Nyxol Eye Drops and APX3330. The Nyxol Eye Drops is a once-daily preservative-free eye drop formulation of phentolamine mesylate designed to reduce pupil diameter and improve visual acuity. Nyxol is being developed for several indications, including night vision disturbances...
Cam Gallagher
Independent Chairman of the Board
Mina Sooch
President, Chief Executive Officer, Vice Chairman of the Board, Treasurer
Amy Rabourn
Principal Accounting Officer, Vice President - Finance
Address
37000 Grand River Ave., Suite 120
Farmington Hills, MI
48335
United States

Top Peers

SYMBOLLASTCHG%CHG
MIRO
Miromatrix Medical Inc
3.15-0.20-5.97%
XFOR
X4 Pharmaceuticals Inc
1.04UNCHUNCH
TSHA
Taysha Gene Therapies Inc
1.21+0.03+2.54%
ADVM
Adverum Biotechnologies Inc
0.70+0.0011+0.1574%
SPRB
Spruce Biosciences Inc
2.91-0.13-4.28%